Horvath A, Blasszauer C, Komka I, Reibl D, et al. Real-World Overall Survival Comparison of Enzalutamide and Abiraterone In First- and Second-Line Setting of Metastatic Castration-Resistant Prostate Cancer. Prostate 2025 Jun 8. doi: 10.1002/pros.24923.
PMID: 40483592